BlueCloud™

ACRES and EXOCHAIN To Accelerate Clinical Research with LYNK BLOCKCHAIN Protocol

The Alliance for Clinical Research Excellence and Safety® signs Agreement with EXOCHAIN™ to Provide Blockchain Technology in Support of Patient and Physician Secure Identity in Clinical Trials. EXOCHAIN CEO and co-founder, Bob Stewart: “Success… depends on trust, accessibility, and immutability of shared data and transparency. This is a perfect use case for EXOCHAIN’s LYNK utility…

Sara Monday Joins ACRES as Vice-President for Site Development and Support

The Alliance for Clinical Research Excellence and Safety (ACRES) welcomes Sara Monday as VP for Site Development and Support, driving ACRES work to strengthen clinical research site performance and improve site interactions with other biomedical stakeholders. CAMBRIDGE, MA (PRWEB) AUGUST 16, 2016 Alliance for Clinical Research Excellence and Safety (ACRES) president and CEO, Dr. Greg Koski,…

Former Sonavation Chief Robert Stewart to Lead ACRES Global IT Initiatives

Robert E. Stewart, Sr. joins the Alliance for Clinical Research Excellence and Safety (ACRES) as Chief Technology Officer and Board member. He will lead the development and implementation of ACRES shared global system IT infrastructure, generating “smart tools” to radically alter the conduct of biomedical research. CAMBRIDGE, MA (PRWEB) APRIL 05, 2016 The Alliance for Clinical…

HealthCarePoint Successfully Completes Global Testing on BlueCloud 2.0 Networking Technology

BlueCloud® 2.0 is enabling industry stakeholders to develop dozens of new business models that reduce costs while improving patient care. “We are witnessing the emergence of a new paradigm in which healthcare and research are coming together as never before” AUSTIN, TEXAS (PRWEB) MARCH 29, 2016 HealthCarePoint (HCP), a Texas-based healthcare and clinical research networking-technology company founded…

ACRES Blue Cloud™ IT Platform Provides Shared Interface for Clinical Research Stakeholders

ACRES BlueCloud™ provides a foundation for a global open-access, integrated IT platform to connect clinical research stakeholders and improve interactions among sponsors, CROs, investigator sites, regulators, ethics committees, patient-participants and providers. Noted Dan O’Connor, President of InnovoCommerce,”This is a milestone for the drug development enterprise…a common platform allowing all players to connect and share information…is…